Author

M. K. Mann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 3 Biochemistry· 2 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 6 Approach:experimental assay· 6 Research Focus:protein structure prediction· 2 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

M. Schapira· 6 shared R. J. Harding· 4 shared C. H. Arrowsmith· 3 shared I. Franzoni· 3 shared C. Arrowsmith· 2 shared D. Barsyte-Lovejoy· 2 shared M. Lautens· 2 shared R. Ferreira de Freitas· 2 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

6 shared papersPharmacology & Toxicology

M. Schapira

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Small molecule screen identifies non-catalytic USP3 chemical handle

M. K. Mann, E. Z. WOLF, M. Silva, B. Wilson, D. J. Wilson, R. J. Harding, M. Schapira

The paper identifies a small molecule ligand for the ZnF-UBD of USP3 with a KD of 14 µM, which could serve as a starting point for developing DUBTACs.

bioRxiv · Mar 1, 2023Biochemistry

Discovery and characterization of a chemical probe targeting the zinc-finger ubiquitin-binding domain of HDAC6

R. J. Harding, I. Franzoni, M. K. Mann, M. Szewczyk, B. Mirabi, D. D. Owens, S. Ackloo, A. Scheremetjew, K. A. Juarez-Ornelas, R. Sanichar, R. J. Baker, C. Dank, P. J. Brown, D. Barsyte-Lovejoy, V. Santhakumar, , C. H. Arrowsmith

The paper identifies and characterizes a chemical probe, SGC-UBD253, that targets the HDAC6 UBD with selectivity, and a less active derivative as a negative control.

bioRxiv · Feb 21, 2023Pharmacology & Toxicology

A combinatorial anticancer drug screen identifies off-target effects of epigenetic chemical probes

S. H. Barghout, M. K. Mann, Y. Yu, A. D. Schimmer, M. Schapira, C. H. Arrowsmith, D. Barsyte-Lovejoy

This study identifies epigenetic chemical probes that enhance TAK-243 cytotoxicity via off-target ABCG2 inhibition and develops a cell-based assay to measure ABCG2 inhibition.

ACS Chemical Biology · Oct 21, 2022Peer-reviewedPharmacology & Toxicology

Structure Activity Relationship of USP5 Allosteric Inhibitors

M. K. Mann, C. A. Zepeda-Velazquez, H. G. Alvarez, A. Dong, T. Kiyota, A. Aman, C. Arrowsmith, R. Al-Awar, R. J. Harding, M. Schapira

This paper develops a chemical series of USP5 allosteric inhibitors, identifies a selective compound with structural and functional characterization.

bioRxiv · May 17, 2021 · PreprintBiochemistry

Discovery of small molecule antagonists of the USP5 zinc finger ubiquitin-binding domain

M. K. Mann, I. Franzoni, R. Ferreira de Freitas, W. Tempel, S. Houliston, C. H. Arrowsmith, R. J. Harding, M. Schapira

The paper identifies small molecule antagonists targeting the USP5 ZnF-UBD, providing a framework for developing chemical probes to study its role in ubiquitin signaling.

bioRxiv · Jun 22, 2019Pharmacology & Toxicology

Identification and Structure-Activity Relationship of HDAC6 Zinc-finger Ubiquitin Binding Domain Inhibitors

R. Ferreira de Freitas, R. Harding, I. Franzoni, M. Ravichandran, M. K. Mann, H. Ouyang, M. Lautens, V. Santhakumar, C. Arrowsmith, M. Schapira

The paper identifies HDAC6 ZnF-UBD inhibitors and describes their structure-activity relationships, revealing key binding features and potential for further optimization.

bioRxiv · Feb 20, 2018Biophysics